NASDAQ:EXPO - Exponent Stock Price, Forecast & News

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Exponent declared a quarterly dividend on Thursday, February 6th. Stockholders of record on Friday, March 13th will be paid a dividend of $0.19 per share on Friday, March 27th. This represents a $0.76 annualized dividend and a dividend yield of 0.95%. The ex-dividend date of this dividend is Thursday, March 12th. This is a positive change from Exponent's previous quarterly dividend of $0.16. View Exponent's Dividend History.

Exponent shares split on the morning of Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly minted shares were distributed to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

Exponent, Inc. (NASDAQ:EXPO) issued its quarterly earnings data on Thursday, February, 6th. The business services provider reported $0.36 EPS for the quarter, topping the Zacks' consensus estimate of $0.33 by $0.03. The business services provider earned $102.22 million during the quarter, compared to analysts' expectations of $96.89 million. Exponent had a net margin of 19.76% and a return on equity of 23.89%. The firm's quarterly revenue was up 19.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.30 earnings per share. View Exponent's Earnings History.

Exponent is scheduled to release their next quarterly earnings announcement on Thursday, April 16th 2020. View Earnings Estimates for Exponent.

5 brokerages have issued 1-year price objectives for Exponent's stock. Their forecasts range from $74.00 to $84.00. On average, they expect Exponent's stock price to reach $79.67 in the next twelve months. This suggests that the stock has a possible downside of 0.7%. View Analyst Price Targets for Exponent.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Exponent.

Media coverage about EXPO stock has been trending somewhat positive on Monday, according to InfoTrie. The research firm ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Exponent earned a media sentiment score of 1.8 on InfoTrie's scale. They also assigned media coverage about the business services provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Exponent.

Exponent saw a drop in short interest during the month of January. As of January 31st, there was short interest totalling 858,500 shares, a drop of 12.8% from the January 15th total of 984,200 shares. Based on an average daily trading volume, of 216,400 shares, the days-to-cover ratio is presently 4.0 days. Currently, 1.7% of the shares of the company are sold short. View Exponent's Current Options Chain.

Some companies that are related to Exponent include Verisk Analytics (VRSK), Equifax (EFX), Nielsen (NLSN), FTI Consulting (FCN), ICF International (ICFI), CBIZ (CBZ), Huron Consulting Group (HURN), Resources Connection (RECN), Franklin Covey (FC), CRA International (CRAI), VSE (VSEC), Mistras Group (MG), Hill International (HIL), Acacia Research (ACTG) and Odyssey Marine Exploration (OMEX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include Energy Transfer LP Unit (ET), AbbVie (ABBV), Ford Motor (F), NetApp (NTAP), AT&T (T), Pfizer (PFE), Twitter (TWTR), Marathon Petroleum (MPC), Activision Blizzard (ATVI) and Abbott Laboratories (ABT).

Exponent's stock is owned by a number of of institutional and retail investors. Top institutional investors include Conestoga Capital Advisors LLC (4.60%), State Street Corp (2.95%), Riverbridge Partners LLC (1.78%), GW&K Investment Management LLC (1.75%), Bank of New York Mellon Corp (1.26%) and Renaissance Technologies LLC (1.04%). Company insiders that own Exponent stock include Carol Lindstrom, Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Paul R Johnston, Richard L Schlenker Jr and Richard Reiss. View Institutional Ownership Trends for Exponent.

EXPO stock was sold by a variety of institutional investors in the last quarter, including PNC Financial Services Group Inc., FMR LLC, Bank of New York Mellon Corp, Royce & Associates LP, Russell Investments Group Ltd., UBS Asset Management Americas Inc., Jacobs Levy Equity Management Inc. and GW&K Investment Management LLC. Company insiders that have sold Exponent company stock in the last year include Carol Lindstrom, Harri Kytomaa, John Pye, Paul R Johnston and Richard L Schlenker Jr. View Insider Buying and Selling for Exponent.

EXPO stock was purchased by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Redwood Investments LLC, Great West Life Assurance Co. Can, TD Asset Management Inc., UBS Group AG, Pennsylvania Trust Co, Aviva PLC and Crown Advisors Management Inc.. View Insider Buying and Selling for Exponent.

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of EXPO stock can currently be purchased for approximately $80.20.

Exponent has a market capitalization of $4.16 billion and generates $417.20 million in revenue each year. The business services provider earns $82.46 million in net income (profit) each year or $1.53 on an earnings per share basis. Exponent employs 1,122 workers across the globe.View Additional Information About Exponent.

The official website for Exponent is http://www.exponent.com/.

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]